The Academic Programs Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the academic legal community. The Committee discusses various programs, publications, pricing, dissemination vehicles, etc. that best facilitate expanding FDLI’s educational mission.

Effective November 10, 2006 | Updated January 9, 2007

> Daniel Dwyer, Chairman, Kleinfeld, Kaplan & Becker

> Barry Berger, GlaxoSmithKline

> James N. Czaban, WilmerHale, LLP

> Kendra Dimond, Huron Consulting Group

> James Dittami

> Lewis Grossman, Covington & Burling

> William Janssen, Charleston Law School

> Philip Katz, Hogan & Hartson, L.L.P.

> William Kitchens, Arnall Golden Gregory LLP

> Anna Mastroianni, University of Washington

> Charles McConachie, Simpson Woolley McConachie, L.L.P.

> Richard Merrill, University of Virginia

> Francis Palumbo, University of Maryland School of Pharmacy

> Sarah Taylor Roller, Covington & Burling

> Peter Safir, Covington & Burling

> William Schultz, Zuckerman Spaeder

> Marc Shapiro, Hyman, Phelps & McNamara, P.C.

> Sheila Shulman, State University of NY at Buffalo

The Drugs and Biologics Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the drugs and biologics industries. The Committee advises staff on the appropriateness of conferences and publications relating to pharmaceuticals and biologics by reviewing and commenting on proposals.

Effective November 10, 2006 | Updated November 30, 2006

> Donald Beers, Chairman, Arnold & Porter, LLP

> Bruce Artim, Eli Lilly and Company

> Alan Bennett, Ropes & Gray

> Douglas Ws. Bierer, Consultant

> Shawn Brown, Generic Pharmaceutical Association

> David Chesney, Parexel

> Howard Dorfman, Bayer Corporation

> Lesley Frank, Regulatory Counsel, FDA

> Marc Goshko, TEVA Pharmaceuticals USA, Inc.

> Prescott Lassman, Pharmaceutical Research and Manufacturers of America

> John Manthei, Latham & Watkins

> Joseph Metro, Reed Smith LLP

> Daniel Michels, Consultant

> Leah Palmer, Amgen Inc.

> Sara Radcliffe, Biotechnology Industry Organization

> Jean Raymond

> Gregory Torre, NPS Pharmaceuticals

> Kathleen E. Swisher, CBER, FDA

Updated April 2008

> Nancy L. Buc, Chair, Buc & Beardsley

> William Schultz, Vice Chair, Zuckerman Spaeder

> Frederick Degnan, Secretary and General Counsel, King & Spalding, LLP

> Linda A. Suydam, Treasurer, Consumer Healthcare Products Assn.

> James Wood, Immediate Past Chairman, Reed Smith LLP

The purpose of the Finance Committee is to ensure the responsible financial operations of FDLI. The Committee provides on-going oversight of the financial operations and investment policies of FDLI to ensure sound financial management. The Committee also advises the Board on the direction and control of financial matters. The Committee also ensures that the Board is well informed about the Institute's finances.

Effective November 10, 2006 | Updated November 30, 2006

> Matthew Weinberg, Chairman, THE WEINBERG GROUP INC.

> Teri Crouse, Eli Lilly and Company

> Maxine Fritz, Quintiles Consulting

> Rady Johnson, Pfizer, Inc.

> Jeffrey Long-McGie, RidgeBack Capital Management, LLC

> Kate Mazan, Clinical Technology Transfer Group

> Robert Merrill, Adolor Corporation

The Food and Dietary Supplements Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the food and dietary supplement industries. The Committee advises staff on the appropriateness of conferences and publications relating to foods and dietary supplements by reviewing and commenting on proposals.

Effective November 10, 2006 | Updated November 30, 2006

> Martin Hahn, Chairman, Hogan & Hartson, L.L.P.

> Susan Bernard, CFSAN, FDA

> Susan Borra, IFIC Foundation

> Nicole Coutrelis, Coutrelis & Associes

> Geraldine Edens, McKenna Long & Aldridge, L.L.P.

> Steven Goldberg, BASF Corporation

> Todd Halpern, Venable LLP

> Craig Henry, Food Products Association

> Claire Kruger, ENVIRON Health Sciences Institute

> Anne Maher, Kleinfeld, Kaplan & Becker

> Steven Mister, Council for Responsible Nutrition

> Michael O'Flaherty, Olsson, Frank and Weeda, P.C.

> Robert Post, FSIS, USDA

> Daniel Shaw, H.J. Heinz Company

> Steven Shapiro, Ullman, Shapiro & Ullman, LLP

> R. Dan Sowards, Texas Department of Health

> Marsha Wertzberger, Arent Fox

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

Effective November 10, 2006 | Updated November 30, 2006

> James Czaban, Chairman, WilmerHale, LLP

> Bruce Patsner, Vice Chairman

> Jeffrey Francer, Biogen Idec, Inc.

>Lewis Grossman, Covington & Burling

>Miriam Guggenheim, Covington & Burling

>Melissa Scales, Keller and Heckman LLP

> Deborah Shelton, Sheppard, Mulllin, Richter & Hampton, LLP

The H. Thomas Austern Writing Awards Committee assists FDLI staff in determining the award recipient(s) for the best student papers submitted for publication. Members of the Committee (with subcommittees for long and short papers) develop publicity for and promote the competition, and subsequently review all submitted student manuscripts, determining which are most appropriate for awards and/or publication.

Effective November 10, 2006 | Updated November 30, 2006

> Philip Katz, Chairman, Hogan & Hartson, L.L.P.

> David Read, Vice Chairman, FDA - CDER/OPS

> Thomas Casola, Merck & Co., Inc.

> Kelly Reeves, King & Spalding, LLP

> Eric Rogers, Genentech, Inc.

> Roseann Termini, Widener University School of Law

The Journal Editorial Advisory Board promotes the educational, scholarly, and other purposes of the Food and Drug Law Journal. Members of the Board serve as peer reviewers for papers submitted for publication and recommend topics for “special / symposia” issues.

Updated April 2008

> Judith Meritz, Chairman, Blank Rome, LLP

> Clay Hough, Vice Chairman, International Dairy Foods Association

> Jeffrey Chasnow, Pfizer, Inc.

> Marsha Cohen, Member

> Philip Derfler, USDA/FSIS

> Melanie Fairchild-Dzanis, Nestle USA-Nutrition Division

> Michael Hacker, Merck & Co., Inc.

> Ralph Hall, University of Minnesota Law School

> Gregory Jaffe, Center for Sci. in the Public Interest

> Gail Javitt, Johns Hopkins University

> Eric Juzenas, Commodity Futures Trading Commission

> Patricia Kaeding, GE Healthcare

> Linda Kahan, FDA - CDRH

> Robert Klepinski, Fredrikson & Byron, P.A.

> Michael Landa, FDA - CFSAN

> Laurie Lenkel, FDA - Office of the Ombudsman

> Mark Levy, Saul Ewing LLP

> Erika Lietzan, Covington & Burling

> Suzanne LoGalbo, Thompson Hine

> Alvin Lorman, Mayer, Brown, Rowe & Maw LLP

> Anne Maher, Kleinfeld, Kaplan & Becker

> Elizabeth McNaughton, Blake, Cassels & Graydon LLP

> Dorothy Watson, Novartis Pharmaceuticals Corporation

> David Weinstock, Boehringer Ingelheim Pharmaceuticals

> Frances Wu, Cosmetic, Toiletry & Fragrance Association

The Medical Devices Committee advises FDLI staff in formulating and implementing policies and strategies consistent with FDLI’s mission, relating to programs and publications of interest to the Medical Devices industries. The Committee advises staff on the appropriateness of conferences and publications relating to medical devices by reviewing and commenting on proposals.

Effective November 10, 2006 | Updated November 30, 2006

> Philip Phillips, Chairman, Becker & Associates Consulting, Inc.

> M. Elizabeth Bierman, Morgan, Lewis & Bockius, LLP

> Sheila Hemeon-Heyer, Boston Scientific Corporation Inc.

> Irene Jakimcius, Baxter International Inc.

> Charma Konnor, Phoenix Regulatory Associates, Ltd.

> Pamela Krop, St. Jude Medical, Inc.

> Mark Leahey, Medical Device Manufacturers Association

> Joanne Less, CDRH, FDA

> Susan Moritz, BD

> Steven Niedelman, Quintiles Consulting

> Garrett Raymond, United States Surgical

> John Reiss, Saul Ewing LLP

> Bradley Thompson, Epstein Becker & Green, P.C.

> Janet Trunzo, AdvaMed

> Andrew Whitman, National Electrical Manufacturers Association

> Edward Wilson, Hogan and Hartson, L.L.P.

Effective November 2, 2005 | Updated November 14, 2005

> Mark DuVal, Chairman, DuVal & Associates, P.A.

> Frederick Branding, McGuireWoods LLP

> Marsha Cohen, Hastings College of the Law

> Bruce Deal, Analysis Group, Inc.

> R. Bruce Dickson, Manatt, Phelps & Phillips, LLP

> Janice Hogan, Hogan & Hartson, L.L.P.

> Paul Hyman, Hyman, Phelps & McNamara, P.C.

> Leslie Krasny, Keller and Heckman LLP

> Laurie Lenkel, FDA - OC

> David Scharf, Baxter International Inc.

> Daniel Shaw, H.J. Heinz Company

The Update Editorial Advisory Board promotes the highest levels of professional, educational, and scholarly written commentary on timely issues of interest to professionals in the areas of foods, drugs, biologics, medical devices, other healthcare technologies, and cosmetics in FDLI’s magazine The Board serves as a resource for FDLI staff to develop feature theme ideas, acquire articles of interest to readers, and advise on the magazine’s quality and success in serving the interests and needs of its readers.

Updated April 2008

> Jeffrey Schomisch, Chairman, Thompson Publishing Group

> Deborah Autor, FDA - CDER

> William Bertrand, MedImmune, Inc.

> Barbara Binzak, Buchanan Ingersoll, P.C.

> Christopher Brown, Genentech, Inc.

> George Burdock, Burdock Group

> Tanya Dobash, Taro Pharmaceuticals USA, Inc.

> Paul Larsen, Consumer Healthcare Products Assn.

> Randall Lutter, FDA - OC

> William McGrath, Wiley Rein LLP

> Robert Nicholas, McDermott, Will & Emery

> Rene Quashie, Fulbright & Jaworski L.L.P.

> Larry Rosania, THE WEINBERG GROUP INC.

> Jeffrey Shapiro, Hogan & Hartson, L.L.P.